I was invited to participate in the Pharma 4.0: Transforming Pharmaceutical Manufacturing event, September 2020.
I was invited to write an article for the American Pharmaceutical Review to discuss the regulatory aspects of filing a continuous process for API. The paper was published in the March 2020 edition, Volume 23, issue 2, pages 26 – 29.
I have already received a lot of positive feedback and interest regarding the content, so I include a link to paper for you to review at your leisure. Please feel free to contact me by email if you would like to schedule a discussion regarding your specific project(s).
